Urist Marshall sold RPRX

December 16, 2025 · Form 4 insider transaction

Urist Marshall sold 20,000 shares of Royalty Pharma plc at $38.32 per share, a transaction worth $766.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Disposed (sell-side)
Shares
20,000
Price
$38.32
Total value
$766.4K
Role—
SecurityClass A Ordinary Shares
Transaction codeS: Open-market sale
Transaction dateDecember 16, 2025
Filing dateDecember 17, 2025
Shares owned after140,000
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

All reported transactions were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on September 16, 2025.; The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.24 to $38.40 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

View the original Form 4 on SEC EDGAR